Hasta la próxima

Auto reproducción

Dr. Massimo Cristofanilli Discusses ALK Amplification in Inflammatory Breast Cancer

3 vistas • 07/03/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

Massimo Cristofanilli, MD, Chair in Medical Oncology, Director of Translational Science, Cancer Genome Institute, Fox Chase Cancer Center, discusses the investigation of small-molecule anaplastic lymphoma kinase (ALK) inhibitors to treat patients with inflammatory breast cancer (IBC).

For more information on targeted therapies, visit http://www.onclive.com/specialty/cancer-pathways

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción